-
1
-
-
33947132490
-
-
American Lung Association [webpage on the Internet], Accessed March 1
-
American Lung Association [webpage on the Internet]. Chronic Obstructive Pulmonary Disease (COPD) Fact Sheet. Available from: http://www.lungusa.org/lung-disease/copd/resources/facts-figures/COPD-Fact-Sheet.html. Accessed March 1, 2016.
-
(2016)
Chronic Obstructive Pulmonary Disease (COPD) Fact Sheet
-
-
-
2
-
-
33847172367
-
TORCH Investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
-
Calverley PMA, Anderson JA, Celli B, et al; TORCH Investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775–789.
-
(2007)
N Engl J Med
, vol.356
, Issue.8
, pp. 775-789
-
-
Calverley, P.1
Erson, J.A.2
Celli, B.3
-
3
-
-
53749102775
-
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
-
Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–1554.
-
(2008)
N Engl J Med
, vol.359
, Issue.15
, pp. 1543-1554
-
-
Tashkin, D.P.1
Celli, B.2
Senn, S.3
-
5
-
-
84873353231
-
Chronic bronchitis and chronic obstructive pulmonary disease
-
Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(3):228–237.
-
(2013)
Am J Respir Crit Care Med
, vol.187
, Issue.3
, pp. 228-237
-
-
Kim, V.1
Criner, G.J.2
-
6
-
-
0345018815
-
NAC: Pharmacological considerations and experimental and clinical applications
-
Cotgreave IA. NAC: pharmacological considerations and experimental and clinical applications. Adv Pharmacol. 1997;38:205–227.
-
(1997)
Adv Pharmacol
, vol.38
, pp. 205-227
-
-
Cotgreave, I.A.1
-
7
-
-
0001582862
-
The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteine
-
Sheffner AL. The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteine. Ann N Y Acad Sci. 1963;106:298–310.
-
(1963)
Ann N Y Acad Sci
, vol.106
, pp. 298-310
-
-
Sheffner, A.L.1
-
8
-
-
33845619406
-
NAC and exacerbations of chronic obstructive pulmonary disease
-
Sutherland ER, Crapo JD, Bowler RP. NAC and exacerbations of chronic obstructive pulmonary disease. J COPD. 2006;3(4):195–202.
-
(2006)
J COPD
, vol.3
, Issue.4
, pp. 195-202
-
-
Sutherland, E.R.1
Crapo, J.D.2
Bowler, R.P.3
-
9
-
-
0033898870
-
The effect of oral NAC in chronic bronchitis: A quantitative systematic review
-
Stey C, Steurer J, Bachmann S, Medici TC, Tramèr MR. The effect of oral NAC in chronic bronchitis: a quantitative systematic review. Eur Respir J. 2000;16(2):253–262.
-
(2000)
Eur Respir J
, vol.16
, Issue.2
, pp. 253-262
-
-
Stey, C.1
Steurer, J.2
Bachmann, S.3
Medici, T.C.4
Tramèr, M.R.5
-
10
-
-
20944433417
-
Effects of NAC on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): A randomised placebo-controlled trial
-
Decramer M, Rutten-van Mölken M, Dekhuijzen PNR, et al. Effects of NAC on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet. 2005;365(9470):1552–1560.
-
(2005)
Lancet
, vol.365
, Issue.9470
, pp. 1552-1560
-
-
Decramer, M.1
Rutten-Van Mölken, M.2
Dekhuijzen, P.3
-
11
-
-
84895803870
-
PANTHEON Study Group. Twice daily NAC 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): A randomised, double-blind placebo-controlled trial
-
Zheng J-P, Wen F-Q, Bai C-X, et al; PANTHEON Study Group. Twice daily NAC 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Lancet Respir Med. 2014;2(3):187–194.
-
(2014)
Lancet Respir Med
, vol.2
, Issue.3
, pp. 187-194
-
-
Zheng, J.-P.1
Wen, F.-Q.2
Bai, C.-X.3
-
14
-
-
84961289978
-
COPDGene Investigators. Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene
-
Kim V, Crapo J, Zha H, et al; COPDGene Investigators. Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene. Ann Am Thorac Soc. 2015;12(3):332–339.
-
(2015)
Ann am Thorac Soc
, vol.12
, Issue.3
, pp. 332-339
-
-
Kim, V.1
Crapo, J.2
Zha, H.3
-
15
-
-
0026566215
-
Preventive administration of intravenous NAC and development of tolerance to isosorbide dinitrate in patients with angina pectoris
-
Boesgaard S, Aldershvile J, Poulsen HE. Preventive administration of intravenous NAC and development of tolerance to isosorbide dinitrate in patients with angina pectoris. Circulation. 1992;85(1):143–149.
-
(1992)
Circulation
, vol.85
, Issue.1
, pp. 143-149
-
-
Boesgaard, S.1
Aldershvile, J.2
Poulsen, H.E.3
-
16
-
-
22244468660
-
Development of a quantifiable symptom assessment tool for patients with chronic bronchitis: The Chronic Bronchitis Symptoms Assessment Scale
-
Au DH, Blough DK, Kirchderfer L, Weiss KB, Udris EM, Sullivan SD. Development of a quantifiable symptom assessment tool for patients with chronic bronchitis: the Chronic Bronchitis Symptoms Assessment Scale. J COPD. 2005;2(2):209–216.
-
(2005)
J COPD
, vol.2
, Issue.2
, pp. 209-216
-
-
Au, D.H.1
Blough, D.K.2
Kirchderfer, L.3
Weiss, K.B.4
Udris, E.M.5
Sullivan, S.D.6
-
17
-
-
0024390384
-
The medical outcomes study: An application of methods for monitoring the results of medical care
-
Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The medical outcomes study: an application of methods for monitoring the results of medical care. JAMA. 1989;262(7):925–930.
-
(1989)
JAMA
, vol.262
, Issue.7
, pp. 925-930
-
-
Tarlov, A.R.1
Ware, J.E.2
Greenfield, S.3
Nelson, E.C.4
Perrin, E.5
Zubkoff, M.6
-
18
-
-
0036697124
-
Isoprostanes as a biomarker of lipid peroxidation in humans: Physiology, pharmacology and clinical implications
-
Cracowski JL, Durand T, Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci. 2002;23(8):360–366.
-
(2002)
Trends Pharmacol Sci
, vol.23
, Issue.8
, pp. 360-366
-
-
Cracowski, J.L.1
Durand, T.2
Bessard, G.3
-
19
-
-
70350036051
-
Measuring the poise of thiol/disulfide couples in vivo
-
Jones DP, Liang Y. Measuring the poise of thiol/disulfide couples in vivo. Free Radic Biol Med. 2009;47(10):1329–1338.
-
(2009)
Free Radic Biol Med
, vol.47
, Issue.10
, pp. 1329-1338
-
-
Jones, D.P.1
Liang, Y.2
-
20
-
-
3042599001
-
Plasma 8- isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia
-
Ahola T, Fellman V, Kjellmer I, Raivio KO, Lapatto R. Plasma 8- isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia. Pediatr Res. 2004;56(1):88–93.
-
(2004)
Pediatr Res
, vol.56
, Issue.1
, pp. 88-93
-
-
Ahola, T.1
Fellman, V.2
Kjellmer, I.3
Raivio, K.O.4
Lapatto, R.5
-
21
-
-
20144362569
-
St. George’s respiratory questionnaire: MCID
-
Jones PW. St. George’s respiratory questionnaire: MCID. J COPD. 2005;2(1):75–79.
-
(2005)
J COPD
, vol.2
, Issue.1
, pp. 75-79
-
-
Jones, P.W.1
-
23
-
-
84893857285
-
Antioxidants accelerate lung cancer progression in mice
-
Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med. 2014;6:221-15.
-
(2014)
Sci Transl Med
, vol.6
, pp. 221-315
-
-
Sayin, V.I.1
Ibrahim, M.X.2
Larsson, E.3
Nilsson, J.A.4
Lindahl, P.5
Bergo, M.O.6
-
24
-
-
0023677293
-
The B-value: A tool for data monitoring
-
Lan KKG, Wittes J. The B-value: a tool for data monitoring. Biometrics. 1988;44(2):579–585.
-
(1988)
Biometrics
, vol.44
, Issue.2
, pp. 579-585
-
-
Lan, K.1
Wittes, J.2
-
25
-
-
25444474448
-
A review of methods for futility stopping based on conditional power
-
Lachin JM. A review of methods for futility stopping based on conditional power. Stat Med. 2005;24(18):2747–2764.
-
(2005)
Stat Med
, vol.24
, Issue.18
, pp. 2747-2764
-
-
Lachin, J.M.1
-
26
-
-
84869110746
-
Glutathione homeostasis and functions: Potential targets for medical interventions
-
Lushchak VI. Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids. 2012;2012:26.
-
(2012)
J Amino Acids
, vol.2012
, pp. 26
-
-
Lushchak, V.I.1
-
27
-
-
0346996689
-
Oxidation of glutathione and cysteine in human plasma associated with smoking
-
Moriarty SE, Shah JH, Lynn M, et al. Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic Biol Med. 2003;35(12):158215–158288.
-
(2003)
Free Radic Biol Med
, vol.35
, Issue.12
, pp. 158215-158288
-
-
Moriarty, S.E.1
Shah, J.H.2
Lynn, M.3
-
28
-
-
33750620057
-
Oxidative stress and redox regulation of lung inflammation in COPD
-
Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J. 2006;28(1):219–242.
-
(2006)
Eur Respir J
, vol.28
, Issue.1
, pp. 219-242
-
-
Rahman, I.1
Adcock, I.M.2
-
29
-
-
34548072307
-
NAC – a safe antidote for cysteine/glutathione deficiency
-
Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. NAC – a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007;7(4):355–359.
-
(2007)
Curr Opin Pharmacol
, vol.7
, Issue.4
, pp. 355-359
-
-
Atkuri, K.R.1
Mantovani, J.J.2
Herzenberg, L.A.3
Herzenberg, L.A.4
-
30
-
-
0028361231
-
Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue
-
Bridgeman MME, Marsden M, Selby C, Morrison D, MacNee W. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax. 1994;49(7):670–675.
-
(1994)
Thorax
, vol.49
, Issue.7
, pp. 670-675
-
-
Bridgeman, M.1
Marsden, M.2
Selby, C.3
Morrison, D.4
Macnee, W.5
-
31
-
-
33646807833
-
Mammalian cysteine metabolism: New insights into regulation of cysteine metabolism
-
Stipanuk MH, Dominy JE Jr, Lee JI, Coloso RM. Mammalian cysteine metabolism: new insights into regulation of cysteine metabolism. J Nutr. 2006;136(6 suppl):1652S–1659S.
-
(2006)
J Nutr
, vol.136
, Issue.6
, pp. 1652S-1659S
-
-
Stipanuk, M.H.1
Dominy, J.E.2
Lee, J.I.3
Coloso, R.M.4
-
32
-
-
0028230612
-
The effect of oral NAC on lung glutathione levels in idiopathic pulmonary fibrosis
-
Meyer A, Buhl R, Magnussen H. The effect of oral NAC on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J. 1994;7(3):431–436.
-
(1994)
Eur Respir J
, vol.7
, Issue.3
, pp. 431-436
-
-
Meyer, A.1
Buhl, R.2
Magnussen, H.3
-
33
-
-
0023263523
-
Normal alveolar epithelial lining fluid contains high levels of glutathione
-
Cantin AM, North SL, Hubbard RC, Crystal RG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol. 1987;63(1):152–157.
-
(1987)
J Appl Physiol
, vol.63
, Issue.1
, pp. 152-157
-
-
Cantin, A.M.1
North, S.L.2
Hubbard, R.C.3
Crystal, R.G.4
-
34
-
-
0033950503
-
Bronchoalveolar lavage fluid urea as a measure of pulmonary permeability in healthy smokers
-
Ward C, Thien F, Secombe J, Gollant S, Walters EH. Bronchoalveolar lavage fluid urea as a measure of pulmonary permeability in healthy smokers. Eur Respir J. 2000;15(2):285–290.
-
(2000)
Eur Respir J
, vol.15
, Issue.2
, pp. 285-290
-
-
Ward, C.1
Thien, F.2
Secombe, J.3
Gollant, S.4
Walters, E.H.5
|